148 related articles for article (PubMed ID: 8069663)
1. Morphine modulates excitatory amino acid-induced activity in the mouse spinal cord: short-term effects on N-methyl-D-aspartate (NMDA) and long-term effects on kainic acid.
Yukhananov RYu ; Larson AA
Brain Res; 1994 May; 646(2):194-200. PubMed ID: 8069663
[TBL] [Abstract][Full Text] [Related]
2. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal.
Kreeger JS; Yukhananov RYu ; Larson AA
Brain Res; 1994 Nov; 663(1):101-6. PubMed ID: 7850459
[TBL] [Abstract][Full Text] [Related]
3. Behavioral sensitization to kainic acid and quisqualic acid in mice: comparison to NMDA and substance P responses.
Sun XF; Larson AA
J Neurosci; 1991 Oct; 11(10):3111-23. PubMed ID: 1719157
[TBL] [Abstract][Full Text] [Related]
4. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists.
Aanonsen LM; Wilcox GL
J Pharmacol Exp Ther; 1987 Oct; 243(1):9-19. PubMed ID: 2822907
[TBL] [Abstract][Full Text] [Related]
5. Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists.
Larson AA; Sun X
J Pharmacol Exp Ther; 1993 Apr; 265(1):159-65. PubMed ID: 7682611
[TBL] [Abstract][Full Text] [Related]
6. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
Larson AA; Sun X
Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
[TBL] [Abstract][Full Text] [Related]
7. Altered N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine is mediated by sigma activity.
Kreeger JS; Yukhananov RYu ; Larson AA
Brain Res; 1995 Feb; 672(1-2):83-8. PubMed ID: 7749756
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of excitatory amino acids by divalent cations. A novel means for distinguishing N-methyl-D-aspartic acid-, kainate- and quisqualate-mediated actions in the mouse spinal cord.
Hornfeldt CS; Larson AA
J Pharmacol Exp Ther; 1989 Dec; 251(3):1064-8. PubMed ID: 2574739
[TBL] [Abstract][Full Text] [Related]
9. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
Velázquez RA; Kitto KF; Larson AA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
[TBL] [Abstract][Full Text] [Related]
10. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
[TBL] [Abstract][Full Text] [Related]
11. Descending systems activated by morphine (ICV) inhibit kainic acid (IT)-induced behavior.
DeLander GE; Wahl JJ
Pharmacol Biochem Behav; 1991 May; 39(1):155-9. PubMed ID: 1718010
[TBL] [Abstract][Full Text] [Related]
12. Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice.
Aanonsen LM; Wilcox GL
Neurosci Lett; 1986 Jun; 67(2):191-7. PubMed ID: 2425302
[TBL] [Abstract][Full Text] [Related]
13. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
DeLander GE; Wahl JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
[TBL] [Abstract][Full Text] [Related]
14. Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord.
Larson AA; Sun X
J Neurosci; 1992 Dec; 12(12):4905-10. PubMed ID: 1281498
[TBL] [Abstract][Full Text] [Related]
15. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
16. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice.
Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T
Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368
[TBL] [Abstract][Full Text] [Related]
17. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn.
Chapman V; Dickenson AH
Brain Res; 1992 Feb; 573(2):321-3. PubMed ID: 1387029
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Blokhina EA; Sukhotina IA; Bespalov AY
Eur J Pharmacol; 2000 Oct; 406(2):227-32. PubMed ID: 11020485
[TBL] [Abstract][Full Text] [Related]
19. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
20. NMDA and non-NMDA receptors mediating nociceptive and non-nociceptive transmission in spinal cord of cat.
Song XJ; Zhao ZQ
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):481-5. PubMed ID: 8010042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
